Mark ZiatsDec 24, 20241 min readThe evolving landscape for compounded GLP-1 drugsA lawsuit from a compounding trade group in October claimed tirzepatide was still in shortage, forcing the FDA to reassess.FDA says tirzepatide shortage is over after taking a second lookhttps://search.app/fZUzQGsJKYDmf1dT8
A lawsuit from a compounding trade group in October claimed tirzepatide was still in shortage, forcing the FDA to reassess.FDA says tirzepatide shortage is over after taking a second lookhttps://search.app/fZUzQGsJKYDmf1dT8
More legal evolution in the compounding GLP-1 (tirzaperitide / Zepbound) sagaFDA Announced Removal of Tirzepatide from the Drug Shortage List https://search.app/1tgc1KWT5tQ1BPyQA
WSJ Article on Stopping OzempicMany patients ask me if they have to 'stay on it forever'-- the answer is no but the emerging data suggest their may be some rebound....
WSJ Article on Sleep and DietOne of the most common compliants I get it sleep related. Interesting article discussing how diet and dietary choices can impact sleep....
Comments